The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C09 | Agents acting on the renin-angiotensin system | |
| 3 | C09D | Angiotensin II antagonists, combinations | |
| 4 | C09DB | Angiotensin II antagonists and calcium channel blockers | |
| 5 | C09DB01 | Valsartan and amlodipine |
| Active Ingredient | Description | |
|---|---|---|
| Valsartan and Amlodipine |
Combination of two antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine belongs to the calcium antagonist class and valsartan to the angiotensin II antagonist class of medicines. The combination of these substances has an additive antihypertensive effect, reducing blood pressure to a greater degree than either component alone. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| COPALIA Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| EXFORGE Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
